Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes

 Abstract

Type 1 diabetes (T1D) is a T-cell mediated autoimmune disease resulting in the destruction of the insulin-secreting β cells. Currently, there is no established clinical approach to effectively suppress long-term the diabetogenic response. Genetic-based vaccination offers a general strategy to reestablish β-cell specific tolerance within the T-cell compartment. The transfer of genes encoding β-cell autoantigens, anti-inflammatory cytokines and/or immunomodulatory proteins has proven to be effective at preventing and suppressing the diabetogenic response in animal models of T1D. The current review will discuss genetic approaches to prevent and treat T1D with an emphasis on plasmid DNA- and adeno-associated virus-based vaccines.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
27 - 36
doi
10.4161/hv.7.1.12848
Type
Special Focus Review
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes